Subtypes of triple-negative breast cancer cell lines react differently to eribulin mesylate

Karen Bräutigam*, Katharina Mitzlaff, Lisa Uebel, Frank Köster, Stephan Polack, Mascha Pervan, Gunnar Steinert, Achim Rody, Cornelia Liedtke

*Corresponding author for this work
2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Subtypes of triple-negative breast cancer cell lines react differently to eribulin mesylate'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology